NCT01333592View on ClinicalTrials.gov

Long-term Study of KAD-1229 in Type 2 Diabetes Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

136

Participants

Timeline

Start Date

Not specified

Primary Completion Date

August 31, 2012

Study Completion Date

November 30, 2012

Conditions
Type 2 Diabetes
Interventions
DRUG

KAD-1229

Trial Locations (1)

Unknown

Japan, Kanto Region, Chugoku Region, Kyushu Region

Sponsors
All Listed Sponsors
lead

Kissei Pharmaceutical Co., Ltd.

INDUSTRY

NCT01333592 - Long-term Study of KAD-1229 in Type 2 Diabetes Patients | Biotech Hunter | Biotech Hunter